Pivovarcikova, K.; Alaghehbandan, R.; Vanecek, T.; Ohashi, R.; Pitra, T.; Hes, O.
TSC/mTOR Pathway Mutation Associated Eosinophilic/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background. Biomedicines 2022, 10, 322.
https://doi.org/10.3390/biomedicines10020322
AMA Style
Pivovarcikova K, Alaghehbandan R, Vanecek T, Ohashi R, Pitra T, Hes O.
TSC/mTOR Pathway Mutation Associated Eosinophilic/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background. Biomedicines. 2022; 10(2):322.
https://doi.org/10.3390/biomedicines10020322
Chicago/Turabian Style
Pivovarcikova, Kristyna, Reza Alaghehbandan, Tomas Vanecek, Riuko Ohashi, Tomas Pitra, and Ondrej Hes.
2022. "TSC/mTOR Pathway Mutation Associated Eosinophilic/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background" Biomedicines 10, no. 2: 322.
https://doi.org/10.3390/biomedicines10020322
APA Style
Pivovarcikova, K., Alaghehbandan, R., Vanecek, T., Ohashi, R., Pitra, T., & Hes, O.
(2022). TSC/mTOR Pathway Mutation Associated Eosinophilic/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background. Biomedicines, 10(2), 322.
https://doi.org/10.3390/biomedicines10020322
